Spots Global Cancer Trial Database for cisplatin injection
Every month we try and update this database with for cisplatin injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| B7-Family Score in Urothelial Carcinoma | NCT06169904 | Urothelial Carc... | Cisplatin injec... | - | Shanghai Zhongshan Hospital | |
| Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer | NCT04444869 | Cancer of the H... Oropharynx Canc... HPV Positive Or... Throat Carcinom... | Cisplatin injec... | 18 Years - | University of Missouri-Columbia | |
| JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations | NCT06380348 | Local Advanced ... | JMT101 Injectio... Osimertinib tab... Cisplatin injec... Pemetrexed inje... | 18 Years - 75 Years | Shanghai JMT-Bio Inc. | |
| Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy | NCT04019548 | Oropharyngeal C... | Percutaneous En... Cisplatin injec... Radiotherapy | 18 Years - | Jules Bordet Institute | |
| Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | NCT04325425 | Neuroendocrine ... | FOLFOXIRI Proto... Cisplatin injec... | 18 Years - | Centre Hospitalier Universitaire Dijon | |
| Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy | NCT03255252 | Cervical Cancer | Cisplatin injec... radiotherapy | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC | NCT06375109 | Limited-stage S... | Tislelizumab Carboplatin inj... Cisplatin injec... Etoposide injec... | 18 Years - 75 Years | Beijing Chest Hospital, Capital Medical University | |
| B7-Family Score in Urothelial Carcinoma | NCT06169904 | Urothelial Carc... | Cisplatin injec... | - | Shanghai Zhongshan Hospital | |
| Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer | NCT01631357 | Non-small Cell ... Squamous Cell C... | CIK cell Gemcitabine Inj... Cisplatin injec... | 18 Years - 80 Years | Tianjin Medical University Cancer Institute and Hospital | |
| B7-Family Score in Urothelial Carcinoma | NCT06169904 | Urothelial Carc... | Cisplatin injec... | - | Shanghai Zhongshan Hospital | |
| Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients | NCT05746598 | Non Small Cell ... Nephropathy Cardiotoxicity | Cisplatin injec... | 18 Years - 80 Years | Ain Shams University | |
| Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | NCT02283489 | Head and Neck N... | recombinant hum... Cisplatin injec... Paclitaxel inje... | 18 Years - 70 Years | Chengdu Shi Endor Biological Engineering Technology Co., Ltd | |
| Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy | NCT04019548 | Oropharyngeal C... | Percutaneous En... Cisplatin injec... Radiotherapy | 18 Years - | Jules Bordet Institute | |
| Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | NCT02283489 | Head and Neck N... | recombinant hum... Cisplatin injec... Paclitaxel inje... | 18 Years - 70 Years | Chengdu Shi Endor Biological Engineering Technology Co., Ltd | |
| Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma | NCT05738057 | Unresectable In... | Camrelizumab Gemcitabine Inj... Cisplatin injec... Cisplatin-Eluti... D-TACE | 18 Years - | Third Affiliated Hospital, Sun Yat-Sen University | |
| Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | NCT04325425 | Neuroendocrine ... | FOLFOXIRI Proto... Cisplatin injec... | 18 Years - | Centre Hospitalier Universitaire Dijon | |
| JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations | NCT06380348 | Local Advanced ... | JMT101 Injectio... Osimertinib tab... Cisplatin injec... Pemetrexed inje... | 18 Years - 75 Years | Shanghai JMT-Bio Inc. | |
| A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors | NCT06116240 | Solid Tumor | TQB2450 injecti... AL2846 capsule Pemetrexed diso... Cisplatin injec... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors | NCT06116240 | Solid Tumor | TQB2450 injecti... AL2846 capsule Pemetrexed diso... Cisplatin injec... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | NCT04325425 | Neuroendocrine ... | FOLFOXIRI Proto... Cisplatin injec... | 18 Years - | Centre Hospitalier Universitaire Dijon |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
